Progenics

From Verify.Wiki
Jump to: navigation, search

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics has two commercial products, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, which is partnered with Bausch Health Companies, Inc.; and AZEDRA, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy.

QuickUpload1048 20170727120829.jpg
http://www.progenics.com
Type Public
Founded 1988
Headquarters New York, New York
Number of employees 51-200 employees


History

Controversies

Top 5 Recent Tweets

DateAuthorComment
January 19, 2021urotodayImplications of PSMA PET imaging for #ProstateCancer. A step towards personalized medicine. Presentation & discussi… https://t.co/3YvQj46lMA
January 19, 2021StockTipRobotStock tip not found. Instead, just sell your human children and buy Progenics Pharmaceuticals Inc. $PGNX #money
January 18, 2021urotodayApplying #ArtificialIntelligence to PSMA-targeted PET #Imaging agent 18F-DCFPyL in #ProstateCancer: lecture & discu… https://t.co/XiCsuRqAUY


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history